Business Combination

6 Months Ended

Apr. 03, 2015

Business Combinations [Abstract]

Business Combination

BUSINESS COMBINATION

In January 2015, one of the Company's German subsidiaries formally launched a voluntary public tender offer to acquire MeVis Medical Solutions AG ("MeVis"), a company based in Bremen, Germany that provides image processing software and services for cancer screening. As of April 3, 2015, the Company segregated restricted cash totaling $34.7 million, which represented the expected total payment to acquire non-par value registered shares of MeVis at a price of €17.50 per share if all outstanding shares were tendered. The restricted cash was included in other assets on the Company's Condensed Consolidated Balance Sheet. On April 21, 2015, the Company completed the acquisition of 73.5% of the then outstanding shares of MeVis using approximately $25.5 million of restricted cash, with the remainder becoming unrestricted. The Company will account for the business combination of MeVis in the third quarter of fiscal year 2015.